Related Experiment Video
Updated: Jan 7, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
Published on: April 25, 2025
Support for 2 variants of eczema
Merci M H Kusel1, Patrick G Holt, Nicholas de Klerk
1Division of Clinical Sciences, Telethon Institute for Child Health Research, 100 Roberts Road, Subiaco, Western Australia.
This study identifies two distinct types of eczema in children: atopic and nonatopic. Risk factors differ between these eczema variants, suggesting tailored approaches for prevention and treatment.
Area of Science:
- Pediatric Dermatology
- Immunology
- Environmental Health
Background:
- Eczema historically viewed as a single condition, overlooking atopic status.
- Up to two-thirds of eczema patients are not atopic, indicating complex associations.
Purpose of the Study:
- Investigate eczema risk factors in relation to atopic status in high-risk children.
- Differentiate between atopic and nonatopic eczema in early childhood.
Main Methods:
- Prospective birth cohort study of 263 children followed for 5 years.
- Data collection via interviews on environmental exposures (antenatal/postnatal).
- Skin prick tests at 6 months, 2, and 5 years to determine atopic status.
Main Results:
- 66.1% of children developed eczema within 5 years; 85.5% had onset in the first year.
- One-third of eczema cases were nonatopic (intrinsic eczema).
- Atopic eczema linked to male sex, longer breastfeeding, food allergies, allergic rhinitis, and wheeze; nonatopic eczema associated with girls and early daycare.
Conclusions:
- Study supports two eczema variants: early-onset atopic eczema and nonatopic eczema linked to daycare.
- Environmental factors likely impact these variants differently.
- Future research should consider these two eczema variants for risk factor analysis.
Related Concept Videos
05:12Murine Nasal Lavage Fluid Collection without Blood Contamination
03:40Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
04:35Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
07:15Intranasal Administration of CNS Therapeutics to Awake Mice

